General MedicationsINTRAMUSCULARGeneric
METRODIN
UROFOLLITROPIN
Standard Dose
75 IU/AMP
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview METRODIN is listed in Drugs@FDA under application 019415 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient UROFOLLITROPIN Form and strength INJECTABLE;INTRAMUSCULAR - 75 IU/AMP Sponsor SERONO Submission history Latest submission status date: 2002-04-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview METRODIN is listed in Drugs@FDA under application 019415 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient UROFOLLITROPIN Form and strength INJECTABLE;INTRAMUSCULAR - 75 IU/AMP Sponsor SERONO Submission history Latest submission status date: 2002-04-15 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.